Cleared Traditional

K172402 - ARIES Group A Strep Assay, ARIES Group A Strep Assay Protocol File Kit (FDA 510(k) Clearance)

Oct 2017
Decision
82d
Days
Class 2
Risk

K172402 is an FDA 510(k) clearance for the ARIES Group A Strep Assay, ARIES Group A Strep Assay Protocol File Kit. This device is classified as a Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System (Class II - Special Controls, product code PGX).

Submitted by Luminex Corporation (Austin, US). The FDA issued a Cleared decision on October 30, 2017, 82 days after receiving the submission on August 9, 2017.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.2680. An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients..

Submission Details

510(k) Number K172402 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 09, 2017
Decision Date October 30, 2017
Days to Decision 82 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PGX - Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.2680
Definition An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients.